The results of the treatment of urothelial cancers affecting upper urinary tracts and, mainly, bladder, present the landscape of suboptimal management of the disease, in which 50% of patients undergoing radical cystectomy does not survive 5 years. Thus, the unmet need of modern urooncology is the sufficient adjuvant treatment in the perioperative setting. Recent advancements in the immunotherapy allow to draw preliminary conclusions on adjuvant treatment to be implemented in new clinical scenarios, including non-muscle invasive disease of the bladder. The recent progresses in the minimally invasive surgical techniques lead to revision of concepts on the treatment of tumors located within upper urinary tracts, as well.
This Special Issue will aim at focusing on novel approaches in the urothelial cancers, including upper urinary tracts and bladder tumors. We search principally for original papers, but also reviews relating to advances in the treatment of Upper Urinary Tract and Bladder Cancers.
The results of the treatment of urothelial cancers affecting upper urinary tracts and, mainly, bladder, present the landscape of suboptimal management of the disease, in which 50% of patients undergoing radical cystectomy does not survive 5 years. Thus, the unmet need of modern urooncology is the sufficient adjuvant treatment in the perioperative setting. Recent advancements in the immunotherapy allow to draw preliminary conclusions on adjuvant treatment to be implemented in new clinical scenarios, including non-muscle invasive disease of the bladder. The recent progresses in the minimally invasive surgical techniques lead to revision of concepts on the treatment of tumors located within upper urinary tracts, as well.
This Special Issue will aim at focusing on novel approaches in the urothelial cancers, including upper urinary tracts and bladder tumors. We search principally for original papers, but also reviews relating to advances in the treatment of Upper Urinary Tract and Bladder Cancers.
